A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults - PubMed (original) (raw)
Clinical Trial
A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults
Kimber L Stanhope et al. Am J Clin Nutr. 2015 Jun.
Abstract
Background: National Health and Nutrition Examination Survey data show an increased risk of cardiovascular disease (CVD) mortality with an increased intake of added sugar.
Objective: We determined the dose-response effects of consuming beverages sweetened with high-fructose corn syrup (HFCS) at zero, low, medium, and high proportions of energy requirements (Ereq) on circulating lipid/lipoprotein risk factors for CVD and uric acid in adults [age: 18-40 y; body mass index (in kg/m(2)): 18-35].
Design: We conducted a parallel-arm, nonrandomized, double-blinded intervention study in which adults participated in 3.5 inpatient days of baseline testing at the University of California Davis Clinical and Translational Science Center's Clinical Research Center. Participants then consumed beverages sweetened with HFCS at 0% (aspartame sweetened, n = 23), 10% (n = 18), 17.5% (n = 16), or 25% (n = 28) of Ereq during 13 outpatient days and during 3.5 inpatient days of intervention testing at the research center. We conducted 24-h serial blood collections during the baseline and intervention testing periods.
Results: Consuming beverages containing 10%, 17.5%, or 25% Ereq from HFCS produced significant linear dose-response increases of lipid/lipoprotein risk factors for CVD and uric acid: postprandial triglyceride (0%: 0 ± 4; 10%: 22 ± 8; 17.5%: 25 ± 5: 25%: 37 ± 5 mg/dL, mean of Δ ± SE, P < 0.0001 effect of HFCS-dose), fasting LDL cholesterol (0%: -1.0 ± 3.1; 10%: 7.4 ± 3.2; 17.5%: 8.2 ± 3.1; 25%: 15.9 ± 3.1 mg/dL, P < 0.0001), and 24-h mean uric acid concentrations (0%: -0.13 ± 0.07; 10%: 0.15 ± 0.06; 17.5%: 0.30 ± 0.07; 25%: 0.59 ± 0.09 mg/dL, P < 0.0001). Compared with beverages containing 0% HFCS, all 3 doses of HFCS-containing beverages increased concentrations of postprandial triglyceride, and the 2 higher doses increased fasting and/or postprandial concentrations of non-HDL cholesterol, LDL cholesterol, apolipoprotein B, apolipoprotein CIII, and uric acid.
Conclusions: Consuming beverages containing 10%, 17.5%, or 25% Ereq from HFCS produced dose-dependent increases in circulating lipid/lipoprotein risk factors for CVD and uric acid within 2 wk. These results provide mechanistic support for the epidemiologic evidence that the risk of cardiovascular mortality is positively associated with consumption of increasing amounts of added sugars. This trial was registered at clinicaltrials.gov as NCT01103921.
Keywords: apolipoprotein CIII; fructose; risk factors; sugar; uric acid.
© 2015 American Society for Nutrition.
Figures
FIGURE 1
Effects of consuming beverages containing 0%, 10%, 17.5%, and 25% Ereq-HFCS. The least squares means (adjusted for sex, BMI, and [outcome] at baseline) ± SEs of (A) Δbody weight; (B) ΔFST and PP plasma non–HDL cholesterol, LDL cholesterol, and apoB concentrations; (C) ΔFST and PP plasma apoCIII concentrations and ΔFST and 24-h mean plasma uric acid concentrations; and (D) ΔFST, 24-h mean, and PP plasma triglyceride concentrations in young men and women after consuming beverages providing 0% (n = 23), 10% (n = 18), 17.5% (n = 16), or 25% (n = 28) of Ereq from HFCS for 2 wk. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, effect of HFCS group; 2-factor (HFCS group, sex) ANCOVA of Δ with adjustment for BMI and [outcome] at baseline. aΔ different from bΔ or bcΔ and abΔ different from cΔ, Tukey’s multiple-comparisons test. +P < 0.05, ++P < 0.01, +++P < 0.001, ++++P < 0.0001, least squares mean different from zero. Significance notations in red indicate that difference did not retain significance after correction for multiple comparisons (P < 0.0031). apoB, apolipoprotein B; apoCIII, apolipoprotein CIII; Ereq, energy requirement; FST, fasting; HFCS, high-fructose corn syrup; PP, postprandial; Δ, absolute change.
FIGURE 2
The 24-h circulating uric acid concentrations during consumption of complex carbohydrate and during consumption of sweetened beverages containing 0%, 10%, 17.5%, and 25% of Ereq-HFCS. Circulating 24-h uric acid plasma concentrations during consumption of energy-balanced baseline diets containing 55% Ereq complex carbohydrate at 0 wk and during consumption of energy-balanced intervention diets containing isocaloric amounts of carbohydrate as complex carbohydrate and (A) 0% Ereq-HFCS (n = 23), (B) 10% Ereq-HFCS (n = 18), (C) 17.5% Ereq-HFCS (n = 15), or (D) 25% Ereq-HFCS (n = 28) at 2 wk. (E) The change in circulating 24-h uric acid plasma concentrations (2 wk – 0 wk) quantified for each group as Δ24-h uric acid AUC. ****P < 0.0001, effect of HFCS group; 2-factor (HFCS group, sex) ANCOVA of Δ with adjustment for BMI and [outcome] at baseline. aΔ different from bΔ, Tukey’s multiple-comparisons test. +P < 0.05, ++++P < 0.0001, least squares mean different from zero. Significance notations in red indicate that difference did not retain significance after correction for multiple comparisons (P < 0.0031). Data are means ± SEs. CHO, carbohydrate; Ereq, energy requirement; HFCS, high-fructose corn syrup; Δ, absolute change.
FIGURE 3
The 24-h circulating triglyceride concentrations during consumption of complex carbohydrate and during consumption of sweetened beverages containing 0%, 10%, 17.5%, and 25% of Ereq-HFCS. Circulating 24-h triglyceride plasma concentrations during consumption of energy-balanced baseline diets containing 55% Ereq complex carbohydrate at 0 wk and during consumption of energy-balanced intervention diets containing isocaloric amounts of carbohydrate as complex carbohydrate and (A) 0% Ereq-HFCS (n = 23), (B) 10% Ereq-HFCS (n = 18), (C) 17.5% Ereq-HFCS (n = 15), or (D) 25% Ereq-HFCS (n = 28) at 2 wk. (E) The change in circulating 24-h triglyceride plasma concentrations (2 wk – 0 wk) quantified for each group as Δ24-h uric acid AUC. *P < 0.05, effect of HFCS group; 2-factor (HFCS group, sex) ANCOVA of Δ with adjustment for BMI and [outcome] at baseline. aΔ different from bΔ, Tukey’s multiple-comparisons test. ++P < 0.01, least squares mean different from zero. Significance notations in red indicate that difference did not retain significance after correction for multiple comparisons (P < 0.0031). Data are means ± SEs. CHO, carbohydrate; Ereq, energy requirement; HFCS, high-fructose corn syrup; Δ, absolute change.
Similar articles
- Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women.
Stanhope KL, Bremer AA, Medici V, Nakajima K, Ito Y, Nakano T, Chen G, Fong TH, Lee V, Menorca RI, Keim NL, Havel PJ. Stanhope KL, et al. J Clin Endocrinol Metab. 2011 Oct;96(10):E1596-605. doi: 10.1210/jc.2011-1251. Epub 2011 Aug 17. J Clin Endocrinol Metab. 2011. PMID: 21849529 Free PMC article. - Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage.
Price CA, Argueta DA, Medici V, Bremer AA, Lee V, Nunez MV, Chen GX, Keim NL, Havel PJ, Stanhope KL, DiPatrizio NV. Price CA, et al. Am J Physiol Endocrinol Metab. 2018 Aug 1;315(2):E141-E149. doi: 10.1152/ajpendo.00406.2017. Epub 2018 Apr 10. Am J Physiol Endocrinol Metab. 2018. PMID: 29634315 Free PMC article. - Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults.
Sigala DM, Hieronimus B, Medici V, Lee V, Nunez MV, Bremer AA, Cox CL, Price CA, Benyam Y, Chaudhari AJ, Abdelhafez Y, McGahan JP, Goran MI, Sirlin CB, Pacini G, Tura A, Keim NL, Havel PJ, Stanhope KL. Sigala DM, et al. J Clin Endocrinol Metab. 2021 Oct 21;106(11):3248-3264. doi: 10.1210/clinem/dgab508. J Clin Endocrinol Metab. 2021. PMID: 34265055 Free PMC article. - Sugar consumption, metabolic disease and obesity: The state of the controversy.
Stanhope KL. Stanhope KL. Crit Rev Clin Lab Sci. 2016;53(1):52-67. doi: 10.3109/10408363.2015.1084990. Epub 2015 Sep 17. Crit Rev Clin Lab Sci. 2016. PMID: 26376619 Free PMC article. Review. - Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people.
Bray GA. Bray GA. Adv Nutr. 2013 Mar 1;4(2):220-5. doi: 10.3945/an.112.002816. Adv Nutr. 2013. PMID: 23493538 Free PMC article. Review.
Cited by
- Interindividual Variability in Postprandial Plasma Fructose Patterns in Adults.
Gladding M, Shen X, Snyder MP, Havel PJ, Adams SH. Gladding M, et al. Nutrients. 2024 Sep 13;16(18):3079. doi: 10.3390/nu16183079. Nutrients. 2024. PMID: 39339679 Free PMC article. - Involvement of microbiota and short-chain fatty acids on non-alcoholic steatohepatitis when induced by feeding a hypercaloric diet rich in saturated fat and fructose.
Milton-Laskibar I, Marcos-Zambrano LJ, Gómez-Zorita S, Carrillo de Santa Pau E, Fernández-Quintela A, Martínez JA, Portillo MP. Milton-Laskibar I, et al. Gut Microbiome (Camb). 2022 Apr 8;3:e5. doi: 10.1017/gmb.2022.2. eCollection 2022. Gut Microbiome (Camb). 2022. PMID: 39295781 Free PMC article. - Sugar and sugar-sweetened beverages in relation to premature aging in adult survivors of childhood cancer.
Lan T, Wang M, Williams AM, Ehrhardt MJ, Jiang S, Huang IC, Lanctot JQ, Krull KR, Armstrong GT, Hudson MM, Colditz GA, Robison LL, Ness KK, Park Y. Lan T, et al. Br J Cancer. 2024 Oct;131(7):1169-1177. doi: 10.1038/s41416-024-02815-3. Epub 2024 Aug 8. Br J Cancer. 2024. PMID: 39117799 - Dynamics of combatting market-driven epidemics: Insights from U.S. reduction of cigarette, sugar, and prescription opioid consumption.
Rimányi E, Quick JD, Yamey G, Immurana M, Malik VS, Doherty T, Jafar Z. Rimányi E, et al. PLOS Glob Public Health. 2024 Jul 24;4(7):e0003479. doi: 10.1371/journal.pgph.0003479. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39047013 Free PMC article. Review.
References
- Richelsen B. Sugar-sweetened beverages and cardio-metabolic disease risks. Curr Opin Clin Nutr Metab Care 2013;16:478–84. - PubMed
- Ervin RB, Ogden CL. Consumption of added sugars among U.S. adults, 2005–2010. NCHS Data Brief 2013;(122):1–8. - PubMed
- Ervin RB, Kit BK, Carroll MD, Ogden CL. Consumption of added sugar among U.S. children and adolescents, 2005–2008. NCHS Data Brief 2012;(87):1–8. - PubMed
- Bravo S, Lowndes J, Sinnett S, Yu Z, Rippe J. Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles. Appl Physiol Nutr Metab 2013;38:681–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 1R01 HL09133/HL/NHLBI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- R01 HL121324/HL/NHLBI NIH HHS/United States
- K12 HD051958/HD/NICHD NIH HHS/United States
- 1R01 HL107256/HL/NHLBI NIH HHS/United States
- UL1 RR024146/RR/NCRR NIH HHS/United States
- R01 HL107256/HL/NHLBI NIH HHS/United States
- R01 HL091333/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources